Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer

By Miyake Kotaro   Shimada Mitsuo   Nishioka Masanori   Sugimoto Koji   Batmunkh Erdenebulgan   Uto Yoshihiro   Nagasawa Hideko   Hori Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 885-892

Springer Publishing Company

Access to resources Recommend Favorite

Bosentan^® inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis

By Dréau Didier   Karaa Amel   Culberson Cathy   Wyan Heather   McKillop Iain   Clemens Mark  

Clinical and Experimental Metastasis, Vol. 23, Iss. 1, 2006-03 ,pp. : 41-53

Springer Publishing Company

Access to resources Recommend Favorite

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

By Murray Lesley   Abrams Tinya   Long Kelly   Ngai Theresa   Olson Lisa   Hong Weiru   Keast Paul   Brassard Jacqueline   O’Farrell Anne   Cherrington Julie   Pryer Nancy  

Clinical and Experimental Metastasis, Vol. 20, Iss. 8, 2003-12 ,pp. : 757-766

Springer Publishing Company

Access to resources Recommend Favorite

The p75^NTR metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells

By Nalbandian Angèle   Djakiew Daniel  

Clinical and Experimental Metastasis, Vol. 23, Iss. 2, 2006-04 ,pp. : 107-116

Springer Publishing Company

Access to resources Recommend Favorite

Piwil2 modulates the invasion and metastasis of prostate cancer by regulating the expression of matrix metalloproteinase-9 and epithelial-mesenchymal transitions

By        

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1735-1740

Spandidos Publications

Access to resources Recommend Favorite